Cite
MLA Citation
F. Valenzuela et al.. “Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient‐reported outcomes from a Phase 3 study.” Journal of the European Academy of Dermatology and Venereology, vol. 30, n.d., pp. 1753–1759. http://access.bl.uk/ark:/81055/vdc_100038780318.0x000037